Remo Moomiaie Qajar

Cytonus Therapeutics Inc. engages in the development of platform of proprietary immunotherapeutic products to treat a wide range of medical conditions. It offers treatments for cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. The company was founded by Dr. Remo Moomiaie-Qajar, and Dr. Richard Klemke in 2018 and is headquartered in Columbus, OH.

Cytonus Therapeutics Inc. engages in the development of platform of proprietary immunotherapeutic products to treat a wide range of medical conditions. It offers treatments for cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. The company was founded by Dr. Remo Moomiaie-Qajar, and Dr. Richard Klemke in 2018 and is headquartered in Columbus, OH.

Cytonus Therapeutics Inc. engages in the development of platform of proprietary immunotherapeutic products to treat a wide range of medical conditions. It offers treatments for cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. The company was founded by Dr. Remo Moomiaie-Qajar, and Dr. Richard Klemke in 2018 and is headquartered in Columbus, OH.